We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.06B
1-Year Est. Return
24.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.35%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$779M
AUM Growth
+$42.2M
(+5.7%)
Cap. Flow
+$272K
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
32.7%
Holding
269
New
2
Increased
1
Reduced
–
Closed
4
Top Buys
| 1 |
Sherwin-Williams
SHW
|
+$3.23M |
| 2 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$993K |
| 3 |
Liberty Global Class C
LBTYK
|
+$985K |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$3.61M |
| 2 |
Liberty Global Class A
LBTYA
|
+$932K |
| 3 |
American International
AIG
|
+$385K |
| 4 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$12K |
Sector Composition
| 1 | Technology | 31.23% |
| 2 | Healthcare | 12.9% |
| 3 | Financials | 12.28% |
| 4 | Communication Services | 11.75% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Henry Schein
HSIC
$10.1B
| $2.62M | 0.34% |
37,815
| – | – |
|
77
Eversource Energy
ES
$28.2B
| $2.6M | 0.33% |
29,994
| – | – |
|
78
Marriott International
MAR
$97.9B
| $2.55M | 0.33% |
17,228
| – | – |
|
79
Lam Research
LRCX
$401B
| $2.54M | 0.33% |
42,500
| – | – |
|
80
State Street
STT
$51.4B
| $2.44M | 0.31% |
28,835
| – | – |
|
81
HCA Healthcare
HCA
$85.6B
| $2.4M | 0.31% |
12,772
| – | – |
|
82
CSX Corp
CSX
$94.6B
| $2.37M | 0.3% |
73,698
| – | – |
|
83
Kimberly-Clark
KMB
$36.2B
| $2.37M | 0.3% |
16,889
| – | – |
|
84
S&P Global
SPGI
$135B
| $2.36M | 0.3% |
6,695
| – | – |
|
85
Mondelez International
MDLZ
$78.8B
| $2.31M | 0.3% |
39,058
| – | – |
|
86
Pfizer
PFE
$143B
| $2.31M | 0.3% |
63,742
| – | – |
|
87
Abbott
ABT
$172B
| $2.28M | 0.29% |
19,031
| – | – |
|
88
Idexx Laboratories
IDXX
$45.4B
| $2.27M | 0.29% |
4,643
| – | – |
|
89
Broadcom
AVGO
$1.78T
| $2.27M | 0.29% |
48,910
| – | – |
|
90
Automatic Data Processing
ADP
$103B
| $2.24M | 0.29% |
11,811
| – | – |
|
91
Biogen
BIIB
$30.8B
| $2.22M | 0.28% |
7,921
| – | – |
|
92
Qualcomm
QCOM
$180B
| $2.17M | 0.28% |
16,391
| – | – |
|
93
Bunge Global
BG
$22.5B
| $2.15M | 0.28% |
27,064
| – | – |
|
94
Trane Technologies
TT
$105B
| $2.14M | 0.27% |
12,904
| – | – |
|
95
Edwards Lifesciences
EW
$50.6B
| $2.09M | 0.27% |
24,984
| – | – |
|
96
Citigroup
C
$221B
| $2.06M | 0.26% |
28,263
| – | – |
|
97
Xcel Energy
XEL
$49.9B
| $2M | 0.26% |
29,639
| – | – |
|
98
CME Group
CME
$89B
| $1.97M | 0.25% |
9,657
| – | – |
|
99
Eli Lilly
LLY
$1.04T
| $1.97M | 0.25% |
10,546
| – | – |
|
100
Chubb
CB
$133B
| $1.96M | 0.25% |
12,371
| – | – |
|
Similar funds
MWA
SFP
CA
WB
BL
RFM
MFS
ECM
Kintegral Advisory's Q1 2021 Portfolio in Review
As of Q1 2021, Kintegral Advisory held 269 positions worth $779M, up 5.7% from $737M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 2.2%. Kintegral Advisory opened 2 new positions and exited 4, leaving the 269-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Kintegral Advisory's largest Q1 2021 buy was American National Group, Inc. Common Stock: 10,180 shares worth $470K.
- Kintegral Advisory added most to Sherwin-Williams in Q1 2021, an estimated $3.23M increase.
- Kintegral Advisory fully exited Tiffany & Co. in Q1 2021, selling an estimated $3.61M.
- Kintegral Advisory's ten largest holdings make up 33% of its $779M portfolio in Q1 2021.
- Kintegral Advisory opened 2 new positions and closed 4 in Q1 2021.
- Kintegral Advisory's portfolio value rose 5.7% quarter-over-quarter to $779M.
Based on Kintegral Advisory's 13F filing for Q1 2021, filed 13 May 2021.